TRAF2 and cancer: Increased expression of STRN was found in different cancers, which induced cell cycle progression and invasiveness by activating downstream transcription factors, including misshapen-like kinase 1, RhoA, TRAF2, NCK-interacting protein kinase and PDGFRA [36].